Nanjing Jianyou Pharmaceutical

Nanjing Jianyou Pharmaceutical is a leading biopharmaceutical company based in China, specializing in the development, manufacturing, and global distribution of heparin-related products and complex injectable generics. The company is recognized as one of the world's largest suppliers of heparin sodium API and has successfully transitioned into a major player in finished dosage forms, including enoxaparin and dalteparin. Through its U.S.-based subsidiary, Meitheal Pharmaceuticals, Nanjing Jianyou has established a robust commercial presence in North America, offering a wide range of generic injectables in therapeutic areas such as oncology, anti-infectives, and intensive care. The company operates state-of-the-art manufacturing facilities that comply with stringent international standards, including US FDA and EU GMP certifications. Nanjing Jianyou continues to invest in its R&D pipeline, focusing on high-barrier generics and biosimilars to address unmet medical needs worldwide.